
A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus
Keywords: BE; Barrett's esophagus; CMS; Center for Medicare and Medicaid Services; CR; complete remission; dQALY; discounted quality-adjusted life-years; EGD; esophagogastroduodenoscopy; HGD; high-grade dysplasia; ICER; incremental cost-effectiveness ratio; LGD; lo